ZY Stock Down 74%, Zymergen Expects No Product Revenue in 2021-2022
Zymergen announced that CEO Josh Hoffman has stepped down and will be replaced by Jay Flatley as the acting Chief Executive Officer.Zymergen Inc (NASDAQ: ZY) stock was down as much as 73.90% during today’s pre-market. According to metrics provided by MarketWatch, ZY stock traded around $9.80 as of August 4,
Read More